This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: Bausch + Lomb Corporation
Today announced the presentation of new scientific data and events taking place during the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in Washington, D.C., April 10-13. Bausch + Lomb Corporation shares T.BLCO are trading down $0.25 at $22.72.
